Clinical Trial: Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07297979) titled 'Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)' on Dec. 09.

Brief Summary: The main objectives of this trial are to determine the recommended dose for expansion of xaluritamig (dose confirmation part only) and to determine the safety and tolerability of xaluritamig in adult, adolescent and pediatric participants with relapsed or refractory EWS.

Study Start Date: Jan. 16, 2026

Study Type: INTERVENTIONAL

Condition: Ewing Sarcoma

Intervention: DRUG: Xaluritamig

Participants will receive xaluritamig via short-term intravenous (IV) infusion.

Recruitment Status: NOT_YE...